Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.
about
Immunotherapy in Multiple Myeloma Using Cancer-Testis AntigensChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsT-cell therapies for HIVCurrent translational and clinical practices in hematopoietic cell and gene therapyAdoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytesEstablishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.Adoptive T-cell therapy: adverse events and safety switches.HIV-specific CD8⁺ T cells and HIV eradicationImmunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation.Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".Will T-cell therapy for cancer ever be a standard of care?Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers.EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas.Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.Virus-Specific T Cells for the Immunocompromised Patient.HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsAdoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies
P2860
Q26774913-BF53CF03-4500-4316-9D40-3941FE3DDB99Q26781511-714381DA-42F6-43BF-95C5-38D37088C8DFQ26866079-2444D2E8-62F7-44B9-B514-8588DA68BA49Q27024456-6B3196DF-A6CC-482A-BC13-C648C8EB393EQ29393780-03BB4C78-BC7E-4511-B575-2C8B541D29FBQ33456742-3CBF5CFF-A41E-44B4-A666-D4D3BEF9C1E7Q33724261-85A8A2E5-3E0B-4EBD-98D6-D3AFB2279CE4Q33733534-530D35F6-FE44-4A08-8E17-753C56B07274Q34511623-51FE9693-F694-4A5F-A306-8D1F682C3C62Q36515071-B9DD5E5F-6FC0-4E13-BA30-CD7960CF666FQ36956443-FFD57620-889C-4F0D-9735-D37B0FD07B76Q37785538-8686D909-CDB5-4109-89F5-4E46E20EFD94Q37919880-9B94C626-A6DD-4E28-B7F5-689CDA1E0C94Q38051546-C2925052-1AEA-45E3-8B61-E17463BF804FQ39272183-DE3C9F6D-8C40-4091-A3B0-99AAC885D233Q40180859-E006C08D-0366-4FFB-8147-50C505604E33Q40441016-B6321480-B2FB-4FCB-8452-6DA059D74C19Q42176262-4DE6B319-4857-417A-A5B7-F46435429DB0Q42654381-0B186ED4-2DD2-48B0-A695-CA153E6E5B17Q57039737-BED0B98F-D952-4D85-8B67-A9EBEC93F9A0Q57172250-F7D3197A-7F51-4A62-BA5F-0B0F9C4710AE
P2860
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adverse events following infus ...... therapy: a 10-year experience.
@ast
Adverse events following infus ...... therapy: a 10-year experience.
@en
Adverse events following infus ...... therapy: a 10-year experience.
@nl
type
label
Adverse events following infus ...... therapy: a 10-year experience.
@ast
Adverse events following infus ...... therapy: a 10-year experience.
@en
Adverse events following infus ...... therapy: a 10-year experience.
@nl
prefLabel
Adverse events following infus ...... therapy: a 10-year experience.
@ast
Adverse events following infus ...... therapy: a 10-year experience.
@en
Adverse events following infus ...... therapy: a 10-year experience.
@nl
P2093
P2860
P1433
P1476
Adverse events following infus ...... therapy: a 10-year experience.
@en
P2093
Adrian P Gee
Ann M Leen
Barbara Savoldo
Catherine M Bollard
Chrystal U Louis
Cliona M Rooney
Conrad Russell Cruz
Gianpietro Dotti
Helen E Heslop
P2860
P304
P356
10.3109/14653241003709686
P577
2010-10-01T00:00:00Z